The demand for aortic endograft in south korea is projected to grow from USD 115.2 million in 2026 to USD 181.6 million by 2036, at a CAGR of 4.7%. Abdominal Aortic Graft will dominate with a 59.0% market share, while endovascular aneurysm repair (evar) will lead the procedure segment with a 67.9% share.